Both in Medical Labs
Aclarion vs BioNexus Gene Lab
Over the past year ACON returned −73.5% and BGLC returned −79.5%; their daily moves had a correlation of 0.12.
ACON −73.5% BGLC −79.5%Growth of $1, one year, split-adjusted
| Metric | ACON | BGLC |
|---|---|---|
| Price | $2.04 | $1.06 |
| Market cap | $5.9M | $3.1M |
| Today | +6.25% | −5.95% |
| 1 month | −14.3% | −16.3% |
| 6 months | −37.4% | −48.4% |
| Year to date | −55.7% | −73.1% |
| 1 year | −73.3% | — |
| Revenue growth (YoY) | +30.5% | −96.6% |
| Gross margin | 32.9% | 17.0% |
| Net margin | −10899.5% | −376.1% |
| P/E (TTM) | — | — |
| Price / sales | 70.2× | 1.0× |
| Net cash | $16.3M | $1.2M |
| Dividend yield | — | — |
| Volatility (60d) | 67.7% | 66.4% |
| Short % of float | 0.9% | 0.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).